ArticleCancers2023

Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384).

Amelie Boquoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.